Show simple item record

dc.contributor.authorShpadaruk, Volha
dc.contributor.authorCarr, Richard
dc.contributor.authorMesiano, Domenico
dc.contributor.authorHeffron, Cinthia
dc.contributor.authorRadonic, Teodora
dc.contributor.authorWiggins, James
dc.contributor.authorTso, Simon
dc.contributor.authorAgrawal, Rishi
dc.contributor.authorCheung, Elaine
dc.contributor.authorSlater, David
dc.contributor.authorCraig, Paul
dc.date.accessioned2023-06-21T11:04:44Z
dc.date.available2023-06-21T11:04:44Z
dc.date.issued2022-07
dc.identifier.citationShpadaruk V, Carr RA, Mesiano D, Heffron C, Radonic T, Wiggings J, Tso S, Agrawal R, Cheung E, Slater D, Craig P. Comparative study of p16, p53 and Ki67 immunostaining indicates that keratoacanthoma and cutaneous squamous cell carcinoma are clinicopathologically distinct entities. British Journal of Dermatology. 2022 Jul;187:25-.en_US
dc.identifier.issn0007-0963
dc.identifier.eissn1365-2133
dc.identifier.doi10.1111/bjd.21113
dc.identifier.urihttp://hdl.handle.net/20.500.14200/1062
dc.description.abstractAbstract for the British Association of Dermatologists 102nd Annual Meeting, 05–07 July 2022.en_US
dc.language.isoenen_US
dc.publisherOxford University Pressen_US
dc.subjectDermatologyen_US
dc.subjectOncology. Pathology.en_US
dc.titleCPC13: Comparative study of p16, p53 and Ki67 immunostaining indicates that keratoacanthoma and cutaneous squamous cell carcinoma are clinicopathologically distinct entitiesen_US
dc.typeConference Output
dc.source.journaltitleBritish Journal of Dermatology
rioxxterms.versionNAen_US
dc.contributor.trustauthorShpadaruk, Volha
dc.contributor.trustauthorCarr, Richard
dc.contributor.trustauthorWiggins, James
dc.contributor.trustauthorTso, Simon
dc.contributor.trustauthorMesiano, Domenico
dc.contributor.departmentDermatologyen_US
dc.contributor.departmentPathologyen_US
dc.contributor.roleMedical and Dentalen_US
dc.contributor.affiliationSouth Warwickshire University NHS Foundation Trust; University Hospitals Coventry and Warwickshire NHS Trust; Cork University Hospital, Ireland; Amsterdam UMC, The Netherlands; New Cross Hospital, Wolverhampton; Queen Elizabeth Hospital, Hong Kong; Chesterfield Royal Hospital; Gloucestershire Hospitals NHS Foundation Trusten_US
oa.grant.openaccessnaen_US


This item appears in the following Collection(s)

Show simple item record